Literature DB >> 7430385

Marrow hypoplasia with splenomegaly in adolescence.

J H Robertson, P Burnside, D C Salmon.   

Abstract

Four adolescents presented with leucopenia, thrombocytopenia, and splenomegaly; three had associated congenital abnormalities and two had a cirrhosis. They provide further evidence of an association between hepatic disease and bone marrow dysfunction. It is considered that these patients suffer from a genetic or constitutional disorder which may result in a susceptibility of their bone marrow to hypoplasia following viral hepatitis or other infections.

Entities:  

Mesh:

Year:  1980        PMID: 7430385      PMCID: PMC1146206          DOI: 10.1136/jcp.33.8.730

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  6 in total

1.  Transient red blood cell aplasia in association with viral hepatitis. Occurrence four years apart in siblings.

Authors:  D A Sears; J N George; M S Gold
Journal:  Arch Intern Med       Date:  1975-12

2.  Congenital (erythroid) hypoplastic anemia. A 25-year study.

Authors:  L K DIAMOND; D M ALLEN; F B MAGILL
Journal:  Am J Dis Child       Date:  1961-09

Review 3.  Disorders of bone marrow production.

Authors:  G E Bloom
Journal:  Pediatr Clin North Am       Date:  1972-11       Impact factor: 3.278

Review 4.  The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature.

Authors:  M J Chusid; D C Dale; B C West; S M Wolff
Journal:  Medicine (Baltimore)       Date:  1975-01       Impact factor: 1.889

5.  Aplastic anaemia with 'hot pockets'.

Authors:  E Kansu; A J Erslev
Journal:  Scand J Haematol       Date:  1976-11

6.  Aplastic anaemia in childhood. 3. Constitutional aplastic anaemia and related cytopenias.

Authors:  D W Hughes
Journal:  Med J Aust       Date:  1974-04-06       Impact factor: 7.738

  6 in total
  1 in total

Review 1.  Bone biopsy in haematological disorders.

Authors:  R Burkhardt; B Frisch; R Bartl
Journal:  J Clin Pathol       Date:  1982-03       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.